Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.
Texto
Imagem
Documentos relacionados
The objective of the present study was to analyze the effect of chemotherapy on the physical condition of patients with advanced non-small cell lung cancer
In crude and multivariate analyses, sociodemographic and medical characteristics (including breast cancer treatments) and patient-reported outcomes at baseline were not associated
Com o crescimento da população idosa e da necessidade de cuidados que visualizem a promoção da sua qualidade de vida, são necessários estudos na área do
Objectives: To determine differences in overall survival and quality of life among patients with stage IV non-small cell lung cancer non-metastatic to the brain treated with
Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern
Findings In this phase 2 trial that enrolled 252 patients with resectable or metastatic gastric or gastroesophageal junction adenocarcinoma, 60 of the 238 eligible patients
Studies were selected if they were randomised controlled phase II to III trials; if they included patients with histologically confirmed, advanced, recur- rent, or
The objective of the present study was to analyze the effect of chemotherapy on the physical condition of patients with advanced non-small cell lung cancer